Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy

BACKGROUND: Two thrombopoietin receptor agonists (TPO-RA), romiplostim and eltrombopag, are currently widely adopted as second-line ITP therapy even in the absence of robust evidence on their comparative advantages over rituximab or splenectomy or their preferential use in some specific clinical con...

Descripción completa

Detalles Bibliográficos
Autores principales: Napolitano, Mariasanta, Vianelli, Nicola, Ghiotto, Lisanna, Cantoni, Silvia, Carli, Giuseppe, Carpenedo, Monica, Carrai, Valentina, Consoli, Ugo, Giuffrida, Gaetano, Lucchini, Elisa, Rossi, Elena, Santoro, Cristina, Rodeghiero, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000838/
https://www.ncbi.nlm.nih.gov/pubmed/36908864
http://dx.doi.org/10.4084/MJHID.2023.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000838/
https://www.ncbi.nlm.nih.gov/pubmed/36908864
http://dx.doi.org/10.4084/MJHID.2023.019

Ejemplares similares